Figure 4

Overall survival in relation to epidermal growth factor receptor 2 (HER2) conversions. Log-rank P = 0.944 (all comparisons); P = 0.582 (PR^-/PR^- versus others); HR = 1.13 (0.73 to 1.74; HER2^-/HER2^- versus others).